文献速递介入腹部神经CT

CT引导腹腔丛/膈脚后内脏神经阻滞治疗非癌性腹痛的单中心回顾性研究

Single-Center Review of Celiac Plexus/Retrocrural Splanchnic Nerve Block for Non-Cancer Related Pain.
PubMed 文献 · Acad Radiol · 2021-04-08

该单中心回顾性研究分析了2011-2020年间72例因非癌性腹痛接受CT引导腹腔丛/膈脚后内脏神经阻滞的病例,总体有效率为67%(48/72),平均缓解51天(中位14天,范围2-700天)。永久性阻滞有效率为50%(9/18),临时性阻滞为72%(39/54);不同适应症的有效率存在差异,如胰腺炎86%、体位性心动过速综合征/自主神经功能障碍77%、术后疼痛62%、正中弓状韧带综合征70%。

要点

  • CT引导CP/RSN阻滞对非癌性腹痛总体有效,但临时与永久阻滞疗效存在差异。
  • 胰腺炎和体位性心动过速综合征/自主神经功能障碍的有效率较高。
  • 腹腔丛与内脏神经阻滞在匹配适应症和阻滞类型后疗效无显著差异。

核心结论

  • CT引导CP/RSN阻滞可有效管理非癌性腹痛,但临时与永久阻滞的疗效存在差异。

研究设计与样本

  • 单中心回顾性研究,纳入2011-2020年间72例CT引导CP/RSN阻滞,分析患者人口学、操作细节、疼痛缓解时长及并发症。

诊断标准与关键数值

  • 有效阻滞定义为:临时阻滞患者报告疼痛缓解或阿片类药物使用减少持续≥2天;永久阻滞持续≥14天。
  • 总体72例中48例(67%)有效,平均缓解51天(中位14天,范围2-700天)。
  • 永久阻滞18例中9例(50%)有效,平均缓解111天(中位90天,范围14-390天)。
  • 临时阻滞54例中39例(72%)有效,平均缓解37天(中位9天,范围2-700天)。
  • 适应症有效率:POTS/自主神经功能障碍77%(20/26)、胰腺炎86%(12/14)、术后疼痛62%(8/13)、MALS 70%(7/10)、慢性疼痛综合征20%(1/5)、胃轻瘫80%(4/5)、肾囊性疾病33%(1/3);在POTS/自主神经功能障碍、胰腺炎、术后疼痛及MALS中,按适应症和阻滞类型匹配后,腹腔丛与内脏神经阻滞的疗效无统计学显著差异。

临床应用与阅片要点

  • 对于非癌性腹痛患者,CT引导CP/RSN阻滞可作为一种治疗选择,尤其对胰腺炎和POTS/自主神经功能障碍患者可能更有效。

局限性

  • 本研究为单中心回顾性设计,样本量有限,可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Celiac plexus and retrocrural splanchnic nerve (CP/RSN) blocks are widely used for cancer-related abdominal pain, but there is limited literature on their efficacy for non-cancer related pain. Our aim was to determine the indications and effectiveness of CT-guided CP/RSN blocks performed on patients with abdominal pain from non-cancer related sources.

MATERIALS AND METHODS: CT-guided CP/RSN blocks for non-cancer related abdominal pain from 2011-2020 were retrospectively reviewed for patient demographics, procedure details, duration of pain relief, and complications. Effective blocks were defined as patient-reported pain relief or decrease in opioid use lasting 2 or more days for temporary blocks and 14 or more days for permanent blocks.

RESULTS: Of 72 CT-guided CP/RSN blocks for non-cancer related abdominal pain, 48 (67%) were effective for a mean of 51 days (median 14, range 2-700). Of the 18 permanent blocks, 9 (50%) were effective for a mean of 111 days (median 90, range 14-390). Of the 54 temporary blocks, 39 (72%) were effective for a mean of 37 days (median 9, range 2-700). Indications included postural orthostatic tachycardia syndrome/dysautonomia (77% effective, 20/26), pancreatitis (86% effective, 12/14), postsurgical pain (62% effective, 8/13), median arcuate ligament syndrome (70% effective, 7/10), chronic pain syndrome (20% effective, 1/5), gastroparesis (80% effective, 4/5), and renal cystic disease (33% effective, 1/3). For postural orthostatic tachycardia syndrome /dysautonomia, pancreatitis, post-surgical pain, and MALS, there were no statistically significant differences in effectiveness between celiac vs. splanchnic blocks in groups matched by indication and intended duration (temporary/permanent).

CONCLUSIONS: CT-guided CP/RSN blocks can effectively manage non-cancer related abdominal pain, though there is discrepancy in efficacy between temporary and permanent blocks.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Liou H, Kong MJ, Alzubaidi SJ, et al. Single-Center Review of Celiac Plexus/Retrocrural Splanchnic Nerve Block for Non-Cancer Related Pain. Acad Radiol. 2021. PMID: 33840601. doi:10.1016/j.acra.2021.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。